Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on tolcapone for cognitive and negative symptoms in schizophrenia stratified by COMT genotype
2013-002713-35Phase 3Active
- Sponsor
- MediPsych
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of tolcapone in schizophrenia (2 arms), sponsored by MediPsych. Started Apr 2014; status: active.
02
Drugs
tolcapone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2013-002713-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002713-35.